Literature DB >> 24874557

Intermittent hypercapnia enhances CO₂ responsiveness and overcomes serotonergic dysfunction.

Bryan P Mosher1, Barbara E Taylor2, Michael B Harris3.   

Abstract

Serotonergic dysfunction compromises ventilatory chemosensitivity and may enhance vulnerability to pathologies such as the Sudden Infant Death Syndrome (SIDS). We have shown raphé contributions to central chemosensitivity involving serotonin (5-HT)-and γ-aminobutyric acid (GABA)-mediated mechanisms. We tested the hypothesis that mild intermittent hypercapnia (IHc) induces respiratory plasticity, due in part to strengthening of GABA mechanisms. Rat pups were IHc-pretreated (eight consecutive cycles; 5 min 5% CO2 - air, 10 min air) or constant normocapnia-pretreated as a control, each day for 5 consecutive days beginning at P12. We subsequently assessed CO2 responsiveness using the in situ perfused brainstem preparation. Hypercapnic responses were determined with and without pharmacological manipulation. Results show IHc-pretreatment induces plasticity sufficient for responsiveness despite removal of otherwise critical ketanserin-sensitive mechanisms. Responsiveness following IHc-pretreatment was absent if ketanserin was combined with GABAergic antagonism, indicating that plasticity depends on GABAergic mechanisms. We propose that IHc-induced plasticity could reduce the severity of reflex dysfunctions underlying pathologies such as SIDS.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemosensitivity; GABA; Respiration; SIDS; Serotonin

Mesh:

Substances:

Year:  2014        PMID: 24874557      PMCID: PMC4167740          DOI: 10.1016/j.resp.2014.05.005

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  36 in total

Review 1.  Breathing: rhythmicity, plasticity, chemosensitivity.

Authors:  Jack L Feldman; Gordon S Mitchell; Eugene E Nattie
Journal:  Annu Rev Neurosci       Date:  2003-02-13       Impact factor: 12.449

2.  Ventilatory responses to hypercapnia and hypoxia following chronic hypercapnia in the rat.

Authors:  T Kondo; M Kumagai; Y Ohta; B Bishop
Journal:  Respir Physiol       Date:  2000-08

Review 3.  Neurochemical development of brain stem nuclei involved in the control of respiration.

Authors:  Margaret T T Wong-Riley; Qiuli Liu
Journal:  Respir Physiol Neurobiol       Date:  2005-11-15       Impact factor: 1.931

Review 4.  Central chemoreception is a complex system function that involves multiple brain stem sites.

Authors:  Eugene Nattie; Aihua Li
Journal:  J Appl Physiol (1985)       Date:  2008-05-08

5.  Respiratory activity in neonatal rats.

Authors:  M Dutschmann; R J Wilson; J F Paton
Journal:  Auton Neurosci       Date:  2000-10-30       Impact factor: 3.145

Review 6.  CO2, brainstem chemoreceptors and breathing.

Authors:  E Nattie
Journal:  Prog Neurobiol       Date:  1999-11       Impact factor: 11.685

Review 7.  Mediation of Ventilatory Adaptations.

Authors:  J A Dempsey; H V Forster
Journal:  Physiol Rev       Date:  1982-01       Impact factor: 37.312

8.  Respiratory plasticity after perinatal hypercapnia in rats.

Authors:  Ryan W Bavis; Rebecca A Johnson; Kari M Ording; Jessica P Otis; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2005-12-09       Impact factor: 1.931

9.  Brainstem PCO2 modulates phrenic responses to specific carotid body hypoxia in an in situ dual perfused rat preparation.

Authors:  Trevor A Day; Richard J A Wilson
Journal:  J Physiol       Date:  2006-11-02       Impact factor: 5.182

10.  Medullary serotonin neurons are CO2 sensitive in situ.

Authors:  Kimberly E Iceman; George B Richerson; Michael B Harris
Journal:  J Neurophysiol       Date:  2013-09-18       Impact factor: 2.714

View more
  1 in total

1.  CO2-inhibited neurons in the medullary raphé are GABAergic.

Authors:  Kimberly E Iceman; Andrea E Corcoran; Barbara E Taylor; Michael B Harris
Journal:  Respir Physiol Neurobiol       Date:  2014-08-01       Impact factor: 1.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.